Canadians have one day left to let the government know how they feel about allowing a private company to pay citizens in exchange for their blood plasma, a controversial question that has health professionals divided on the safety and supply of the life-saving fluid.
What do policymakers think about pharmacies discounting their fees while at the same time lobbying them for more money? I asked two of the leaders behind Ontario’s drug reforms about the controversial practice.